2nd Quarter - Report — HARM REDUCTION COALITION for HARM REDUCTION COALITION (2013)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

HARM REDUCTION COALITION

Client

HARM REDUCTION COALITION

Income

$20,000

Expenses

—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
2nd Quarter - Report (this page)	Jul 27, 2013	$20,000	Replaced
2nd Quarter - Termination (No Activity)	Jul 31, 2015	—	Replaced
2nd Quarter - Termination Amendment (No Activity)	Feb 3, 2016	—	Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Viral hepatitis testing and treatment

Lobbyist	Covered position, as disclosed
WHITNEY ENGLANDER	—

Contacted: Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH)

Alcohol and Drug Abuse ALC

Overdose prevention and naloxone access Access to addiction treatment, specifically access to medication assisted treatment Viral hepatitis testing and treatment

Lobbyist	Covered position, as disclosed
WHITNEY ENGLANDER	—

Contacted: Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.